Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9358558 | 0.80 | ALDH1A1 (0.41) | C5AR1PTPN1ALDH1A1POLBNPC1 | |
| SCHEMBL8672113 | 0.80 | ALDH1A1 (0.41) | C5AR1PTPN1ALDH1A1POLBNPC1 | |
| SCHEMBL8066324 | 0.77 | ALDH1A1 (0.40) | C5AR1ALDH1A1POLBNPC1PKM | |
| SCHEMBL756089 | 0.75 | MAPT (0.38) | ALDH1A1NPC1RAB9ALMNAHTT | |
| SCHEMBL7296721 | 0.74 | C5AR1 (0.37) | C5AR1PTPN1ALOX5ALDH1A1POLB | |
| SCHEMBL3631013 | 0.72 | C5AR1 (0.38) | C5AR1PTPN1ALOX5ALDH1A1POLB | |
| SCHEMBL299734 | 0.72 | KMT2A (0.44) | C5AR1PTPN1ALOX5ALDH1A1POLB | |
| SCHEMBL9715199 | 0.72 | MEN1 (0.47) | ALDH1A1NPC1RAB9AHTTMEN1 | |
| SCHEMBL13740946 | 0.72 | ALDH3A1 (0.37) | ALDH1A1DRD3ESR1 | |
| SCHEMBL10819024 | 0.71 | HPGD (0.49) | PTPN1ALDH1A1NPC1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3310819-B1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | BASF SE (DE) | 2018-06-21 | — | — | US | disclosed |
| EP-3310819-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2018-04-25 | — | — | EP | disclosed |
| WO-2016202883-A1 | COMPOSITION FOR IMMEDIATELY ENDING RADICAL POLYMERIZATION | BASF SE (DE) | 2016-12-22 | — | — | WO | disclosed |
| EP-1025132-B1 | METHOD AND SOLUTION FOR IMMEDIATE TERMINATION OF RADICAL POLYMERISATION | BASF AG (DE) | 2004-03-03 | — | — | EP | disclosed |
| US-6518374-B1 | Inhibitor solution, containing at least 10% phenothiazine, from 5 to 10% p-methoxyphenol and at least 50% N-methylpyrrolidone | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-11 | — | — | US | disclosed |
| US-6518452-B1 | A method of stabilizing an ester of (meth)acrylic acid against free-radical polymerization, comprising: adding to said ester of (meth)acrylic acid a polymerization inhibitor which comprises at least one nitroxyl radical and/or at least | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-11 | — | — | US | disclosed |
| EP-1177218-B1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AG (DE) | 2002-12-11 | — | — | EP | disclosed |
| EP-1177218-A1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-06 | — | — | EP | disclosed |
| US-H1957-H1 | ADDING A PHENOTHIAZINE-CONTAINING SOLUTION WHOSE SOLVENT COMPRISES AT LEAST 50% OF ITS WEIGHT OF AN N-ALKYLPYRROLIDONE | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-03 | — | — | US | disclosed |
| WO-2000064947-A1 | METHOD OF IMMEDIATELY TERMINATING FREE-RADICAL POLYMERISATION PROCESSES | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221255-B2 | Composition for the immediate stopping of a free-radical polymerization | FASTKD5, TYK2, FASTKD1 | C5AR1 4561/4885PTPN1 781/4885ALOX5 258/4885 |
| US-20180171035-A1 | COMPOSITION FOR THE IMMEDIATE STOPPING OF A FREE-RADICAL POLYMERIZATION | FASTKD5, TYK2, FASTKD1 | C5AR1 4561/4885PTPN1 781/4885ALOX5 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.